These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9207307)

  • 1. The emerging role of gemcitabine in lung cancer.
    Bunn PA
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-1. PubMed ID: 9207307
    [No Abstract]   [Full Text] [Related]  

  • 2. The emerging role of gemcitabine in lung cancer: part I.
    Bunn PA
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-1. PubMed ID: 9194472
    [No Abstract]   [Full Text] [Related]  

  • 3. Gemcitabine: symptomatic benefit in advanced non-small cell lung cancer.
    Thatcher N; Jayson G; Bradley B; Ranson M; Anderson H
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-6-S8-12. PubMed ID: 9207309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine--status of preclinical studies and perspectives for future clinical applications of this novel nucleoside analog. Symposium proceedings. Amsterdam, The Netherlands, March 15, 1994.
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):1-82. PubMed ID: 7481838
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of single-agent gemcitabine in advanced non-small cell lung cancer: a review.
    Hansen HH; Sørensen JB
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-38-S7-41. PubMed ID: 9194478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of gemcitabine toxicity with a brief course of oral corticosteroid therapy.
    Vander Els NJ; Miller V
    Chest; 1998 Dec; 114(6):1779-81. PubMed ID: 9872221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine plus radiotherapy for non-small cell lung cancer.
    Gregor A
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-39-S8-41. PubMed ID: 9207316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis--a case report.
    Chen YM; Chen MC; Tsai CM; Perng RP
    Lung Cancer; 2003 Apr; 40(1):99-101. PubMed ID: 12660014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoradiation in NSCLC: focus on the role of gemcitabine.
    Choy H
    Oncology (Williston Park); 2004 Jul; 18(8 Suppl 5):38-42. PubMed ID: 15339058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-agent gemcitabine in non-small cell lung cancer: the French experience.
    Le Chevalier T; Gottfried M
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-47-S7-49. PubMed ID: 9194480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer.
    Liu D; Kojima T; Ouchi M; Kuroda S; Watanabe Y; Hashimoto Y; Onimatsu H; Urata Y; Fujiwara T
    Mol Cancer Ther; 2009 Apr; 8(4):980-7. PubMed ID: 19372571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer.
    Manegold C; Drings P; von Pawel J; Ricci S; Dornoff W; van Walree N; ten Bokkel Huinink W; Chemaissani A; Stahel P; Bergman B; Wagenius G; Sederholm C; Mattson K; Liippo K; Kellokumpu-Lehtinen P
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-13-S8-17. PubMed ID: 9207310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine: new indication. Relapsed ovarian cancer: simply more toxic. Increases haematologic toxicity but not overall survival.
    Prescrire Int; 2009 Aug; 18(102):156. PubMed ID: 19746525
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II studies of gemcitabine for non-small cell lung cancer in Japan.
    Fukuoka M; Takada M; Yokoyama A; Kurita Y; Niitani H
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-42-S7-46. PubMed ID: 9194479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization by gemcitabine.
    Lawrence TS; Eisbruch A; McGinn CJ; Fields MT; Shewach DS
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):55-60. PubMed ID: 10550827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer.
    Shepherd FA; Abratt RP; Anderson H; Gatzemeier U; Anglin G; Iglesias J
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-50-S7-55. PubMed ID: 9194481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine (Gemzar) in non-small cell lung cancer.
    Manegold C
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):345-60. PubMed ID: 15161434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module.
    Evans WK
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-56-S7-63. PubMed ID: 9194482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival under maintenance gemcitabine chemotherapy for metastatic transitional cell carcinoma.
    Lehmann J; Retz M; Siemer S; Schreier U; Zwergel U; Stöckle M
    Int J Urol; 2006 Jul; 13(7):1035-6. PubMed ID: 16882086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine-induced acute eosinophilic pneumonia.
    Kim YH; Mishima M; Yoshizawa A
    J Thorac Oncol; 2010 Aug; 5(8):1308-9. PubMed ID: 20661093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.